Büyüktimkin S, Buschauer A, Schunack W
Fakultät für Pharmazie, Universität Istanbul, Türkei.
Arch Pharm (Weinheim). 1991 May;324(5):291-5. doi: 10.1002/ardp.19913240507.
A series of (2-aryl-2,3-dihydro-4(1H)-quinazolinon-1-yl)alkyl-substituted cyanoguanidines and ureas with histamine, cimetidine or roxatidine partial structure was prepared and tested for H1- and H2-antagonism at the isolated ileum and the isolated right atrium of the guinea-pig. All compounds investigated were only very weak H1-antagonists, whereas the 3-[3-(1-piperidinyl-methyl)phenoxy]propyl-cyanoguanidines and -ureas were more potent H2-antagonists than cimetidine, maximally achieving about ranitidine's potency.